Multidrug resistance of bacteria has prompted intensive development work on new
medicines, but also the search for effective options among the oldest antibiotics. Although …

Introduction Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated
bacterial pneumonia (VABP) continue to be common infections causing significant morbidity …

Introduction The rising challenge of carbapenem-resistant Enterobacterales (CRE)
infections in Indian healthcare settings calls for clear clinical guidance on the management …

Objectives Data on the use of intravenous (IV) fosfomycin in Canada are limited. Using data
captured by the Canadian LEadership on Antimicrobial Real-life usage (CLEAR) registry …

Fosfomycin in intravenous (IV) formulation has re-emerged as a valuable tool in the
treatment of multi-drug resistant (MDR) and extensively drug-resistant (XDR) infections …

Background In Thailand, active antibiotics against Gram-negative bacteria are limited. The
re-emergence of intravenous (IV) fosfomycin is an alternative. IV fosfomycin has broad …

This retrospective study aimed to evaluate the clinical use and side effects of fosfomycin in
critically ill patients in Taiwan. Forty-two patients (mean age, 69.9 years; female, 69%) who …

SUMMARY OBJECTIVE: The aim of this study was to evaluate the combination treatments
with intravenous fosfomycin for carbapenem-resistant Klebsiella pneumoniae infections in a …

Materials and Methods: A retrospective observational study on the characteristics and
clinical outcomes of patients who received fosfomycin as definitive therapy from 2016 to …